ARTICLE | Clinical News
Angiomax bivalirudin: Completed Phase IIIb trial enrollment
March 5, 2001 8:00 AM UTC
The Medicines Co. (MDCO), Cambridge, Mass. Product: Angiomax bivalirudin Business: Cardiovascular Therapeutic category: Thrombolysis/Thrombosis Target: Thrombin Description: Anticoagulant thrombin in...